This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings-outlook: Archive
Xerox Holdings Corporation (XRX) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Xerox (XRX) delivered earnings and revenue surprises of -740.00% and -0.75%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
XRXPositive Net Change CLIRNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
HF Sinclair (DINO) Q2 Earnings Beat Estimates
by Zacks Equity Research
HF Sinclair (DINO) delivered earnings and revenue surprises of +55.96% and -5.77%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
DINOPositive Net Change MPCPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
ITT (ITT) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
ITT (ITT) delivered earnings and revenue surprises of +1.23% and +2.70%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ITTNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Norwegian Cruise Line (NCLH) Q2 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Norwegian Cruise Line (NCLH) delivered earnings and revenue surprises of -1.92% and -1.55%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
NCLHNegative Net Change LINDNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
CVS Health (CVS) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
CVS Health (CVS) delivered earnings and revenue surprises of +23.13% and +5.54%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CVSPositive Net Change ESTAPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
BorgWarner (BWA) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
BorgWarner (BWA) delivered earnings and revenue surprises of +14.15% and +2.31%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
BWANegative Net Change XPELNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Cameco (CCJ) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Cameco (CCJ) delivered earnings and revenue surprises of +41.67% and +0.49%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CCJNegative Net Change WPMPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
CMS Energy (CMS) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
CMS Energy (CMS) delivered earnings and revenue surprises of +5.97% and +8.94%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CMSPositive Net Change DUKPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Agios Pharmaceuticals (AGIO) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
Agios Pharmaceuticals (AGIO) delivered earnings and revenue surprises of -10.92% and +34.18%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
AGIONegative Net Change MIRMNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Cenovus Energy (CVE) Q2 Earnings Surpass Estimates
by Zacks Equity Research
Cenovus (CVE) delivered earnings and revenue surprises of +135.71% and -2.49%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CVENegative Net Change IMOPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
SNDL Inc. (SNDL) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
SNDL INC (SNDL) delivered earnings and revenue surprises of +125.00% and +6.13%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
SNDLNegative Net Change MGNXPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Xcel Energy (XEL) Surpasses Q2 Earnings Estimates
by Zacks Equity Research
Xcel (XEL) delivered earnings and revenue surprises of +19.05% and -0.84%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
XELPositive Net Change NIPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Biogen Inc. (BIIB) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Biogen (BIIB) delivered earnings and revenue surprises of +39.19% and +13.89%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
BIIBNegative Net Change CRBUNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Wesco International (WCC) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Wesco International (WCC) delivered earnings and revenue surprises of +2.42% and +1.99%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
WCCNegative Net Change AVTNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Willis Towers Watson (WTW) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Willis Towers Watson (WTW) delivered earnings and revenue surprises of +7.92% and +1.20%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
WTWNegative Net Change EHTHNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Air Products and Chemicals (APD) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Air Products and Chemicals (APD) delivered earnings and revenue surprises of +3.69% and +0.18%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
APDNegative Net Change KOPNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Aurinia Pharmaceuticals (AUPH) Q2 Earnings Miss Estimates
by Zacks Equity Research
Aurinia (AUPH) delivered earnings and revenue surprises of -5.88% and +10.41%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
AUPHNegative Net Change XNCRPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Lincoln National (LNC) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Lincoln National (LNC) delivered earnings and revenue surprises of +23.56% and +1.23%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
LNCPositive Net Change BWINPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
PG&E (PCG) Q2 Earnings and Revenues Miss Estimates
by Zacks Equity Research
PG&E (PCG) delivered earnings and revenue surprises of -6.06% and -6.65%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
PCGPositive Net Change CTRIPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
City Office REIT (CIO) Q2 FFO Meet Estimates
by Zacks Equity Research
City Office REIT (CIO) delivered FFO and revenue surprises of 0.00% and -1.06%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CIONo Net Change CTRENegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Integra LifeSciences (IART) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Integra (IART) delivered earnings and revenue surprises of +4.65% and +5.05%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
IARTPositive Net Change IDXXPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
KBR Inc. (KBR) Q2 Earnings Beat Estimates
by Zacks Equity Research
KBR (KBR) delivered earnings and revenue surprises of +3.41% and -5.17%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
KBRNegative Net Change ACMNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Proto Labs (PRLB) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Proto Labs (PRLB) delivered earnings and revenue surprises of +24.24% and +6.35%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
PRLBNegative Net Change CMTPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Cigna (CI) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Cigna (CI) delivered earnings and revenue surprises of +0.84% and +7.09%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CIPositive Net Change JYNTPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Amadeus IT Group SA Unsponsored ADR (AMADY) Q2 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Amadeus IT Group (AMADY) delivered earnings and revenue surprises of -1.04% and -0.93%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
AMADYNegative Net Change DGXXNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank